SKIN vs HNST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HNST Captures Institutional Edge (3โ1 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to The Honest Company, Inc. Common Stock (HNST) driven by superior Valuation, Growth & Margin, Options & Structure while SKIN counters with relative strength in Momentum & Technical. Fundamentally, SKIN trades at 106.4x Forward P/E with 2.4% operating margin (-2.1% YoY revenue) versus HNST at 43.5x Forward P/E and 2.4% operating margin (-8.6% YoY). In options structure, SKIN sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against HNST sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SKIN Revenue | HNST Revenue | SKIN Op. Margin | HNST Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $170M | $240M | 8.1% | -13.4% | SKIN |
| FY2020 | $120M | $300M | -14.4% | -4.5% | HNST |
| FY2021 | $260M | $320M | -15.4% | -11.6% | HNST |
| FY2022 | $370M | $310M | -7.1% | -15.9% | SKIN |
| FY2023 | $400M | $340M | -32.9% | -11.3% | HNST |
| FY2024 | $330M | $380M | -20.3% | -1.7% | HNST |
| FY2025 | $300M | $370M | -6.9% | -5.0% | HNST |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SKIN | HNST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $106.3M | $547.1M | Larger Scale | HNST |
| Trailing P/E Ratio Valuation | 106.4x | 7.3x | Lower Multiple | HNST |
| Forward P/E Ratio Valuation | 106.4x | 43.5x | Lower Multiple | HNST |
| Revenue Growth (YoY) Growth | -2.1% | -8.6% | Higher Growth | SKIN |
| Operating Margin (TTM) Profitability | 2.4% | 2.4% | Higher Margin | Tie |
| Net Profit Margin Profitability | -6.3% | 23.5% | Higher Margin | HNST |
| Return on Equity (ROE) Capital Efficiency | -30.1% | 34.6% | Higher ROE | HNST |
| 52-Week Range Position Momentum | 83% ($0โ$18) | 71% ($2โ$6) | Stronger Trend | SKIN |
| Beta / 30D Volatility Risk Regime | -14.22ฮฒ ยท 192% Vol | 1.09ฮฒ ยท 66% Vol | Lower Realized Risk | HNST |
| Unified Institutional Score Composite Signal | 34.1 / 100 (SELL) | 36.7 / 100 (SELL) | Higher Composite | HNST |